Science Explorer Back to mapMap

Most cited papers from Molecule Works (United States)

What are the most cited papers from Molecule Works (United States)?

The most cited paper from Molecule Works (United States) is "Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism" (Kathleen Connery, Marie Tippett, Leanna M. Delhey et al., 2018), with 64 citations. Next come "Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms" (60) and "Low temperature upcycling of polyethylene to gasoline range chemicals: Hydrogen transfer and heat compensation to endothermic pyrolysis reaction over zeolites" (21).

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism Kathleen Connery, Marie Tippett, Leanna M. Delhey et al. · Translational Psychiatry Open access 10 Aug 2018 64
2 Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms Craig D. Shimasaki, Richard E. Frye, Rosario Rich Trifiletti et al. · Journal of Neuroimmunology Open access 14 Dec 2019 60
3 Low temperature upcycling of polyethylene to gasoline range chemicals: Hydrogen transfer and heat compensation to endothermic pyrolysis reaction over zeolites Changle Jiang, Yuxin Wang, Thang M. Luong et al. · Journal of environmental chemical engineering Open access 3 Mar 2022 21
4 What is Biotechnology Entrepreneurship? Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 12
5 Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery Amy Rachael Cross, Denis Bouboulis, Craig D. Shimasaki et al. · Frontiers in Psychiatry Open access 2 Feb 2021 11
6 Reliability of the Cunningham Panel Richard E. Frye, Craig D. Shimasaki · Translational Psychiatry Open access 8 Apr 2019 8
7 Understanding Biotechnology Business Models and Managing Risk Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 5
8 Understanding Biotechnology Product Sectors Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 5
9 Directing Your Technology Toward a Market Problem: What You Need to Know Before Using the Business Model Canvas? Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 4
10 Biotechnology Products and Their Customers: Developing a Successful Market Strategy Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 4
11 Investor Presentations: What Do You Need in an Investor Pitch Deck? Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 3
12 Technology Opportunities Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 2
13 Company Growth Stages and the Value of Corporate Culture Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 2
14 Mentorship: Why You Need a Team of Mentors to be Successful Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 2
15 Five Essential Elements for Growing Biotechnology Clusters Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 2
16 Termination of pre-mRNA splicing requires that the ATPase and RNA unwindase Prp43 acts on the catalytic snRNA U6 Rebecca Toroney, Klaus Nielsen, Jonathan P. Staley · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 4 Jun 2019 1
17 Sources of Capital and Investor Motivations Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 1
18 Summary Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 0
19 Five Essential Elements and Regional Influences Required To Grow and Expand a Biotechnology Cluster or Hub Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 0
20 Common Biotechnology Entrepreneur Mistakes and How to Avoid Them Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 0
21 Understanding and Securing Venture Capital: An Entrepreneur’s Perspective Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 0
22 Understanding and Securing Venture Capital Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 0
23 Technology Opportunities: Evaluating the Idea Craig D. Shimasaki · Elsevier eBooks Book chapter 2020 0
24 Summary Craig D. Shimasaki · Elsevier eBooks Book chapter 2014 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.